Parametrica Management LTD Global Blood Therapeutics, Inc. Transaction History

Parametrica Management LTD

  • $83.5 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$25.48 - $37.34 $618,527 - $906,428
-24,275 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$32.46 - $43.42 $8,212 - $10,985
253 Added 1.05%
24,275 $850,000
Q1 2021

May 14, 2021
BUY
$38.94 - $50.85 $935,416 - $1.22 Million
24,022 New
24,022 $979,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Parametrica Management LTD Portfolio

Follow Parametrica Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email